This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Top 10 Penny Stocks of 2010

Stocks in this article: ZANE STBK

3. Radient Pharmaceuticals (RPC) is an integrated pharmaceutical company, based in Tustin, Calif., focused on cancer and cancer testing. The stock failed to close above $1 after June 5, 2009, finishing the year at 24 cents.

Closing Price: $1.16 (June 16)

Total Return (YTD): 383.9%

Developments in 2010: In early April, Radient said it entered into an exclusive five-year collaboration agreement with Jaiva Technologies to conduct clinical trials for Radient's cancer therapy and vaccine technology in India. Radient said its monoclonal antibody test, which it began working on 20 years ago, "may change how people screen for early cancer detection." The stock jumped to a 52-week high of $2.59 before Radient announced a dilutive financing deal, which dropped shares back down to $1. In May, Radient announced a collaboration agreement with Provista Life Sciences for its Onko-Sure cancer test.

Valuation: Radient's news releases in April sparked a speculative trading frenzy, which came to a screeching halt when the company capitalized on the rapid increase in share price with the financing deal. The fear of another capital raising on another increase in share price will likely be on the minds of Radient investors. Looking at valuation, Radient offers value on a price-to-book (1.43) and a price-to-sales (2.96) basis, according to Bloomberg. That compares to the average of the pharmaceuticals and biotech sector (5.61 and 35.21, respectively).

8 of 10

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs